Skip to main content
Top
Published in: Breast Cancer 2/2018

01-03-2018 | Rapid Communication

Trends in the clinical stage distribution of breast cancer in Osaka, Japan

Authors: Yasuhiro Toyoda, Takahiro Tabuchi, Tomio Nakayama, Shigeyuki Hojo, Setsuko Yoshioka, Yukiko Wakabayashi, Yoshiichi Maeura

Published in: Breast Cancer | Issue 2/2018

Login to get access

Abstract

We examined the proportion of screen-detected breast cancer cases and clinical stage distribution by age group among female breast cancer cases in Osaka, Japan using population-based cancer registry from the period 1980 to 2012. The proportion of local cases increased and that of regional cases decreased gradually during the study period. The proportion of distant cases leveled off. The proportion of in situ cases increased rapidly after 2003. This increase was noticeable for women aged 30–39, 40–49, 50–59, and 60–69 years. The proportion of in situ cases for women aged 40–49, 50–59, and 60–69 years reached 15.4, 11.3, and 9.9% in 2010–2012, respectively. Regarding screening status, the proportion of screen-detected cases before 1988 was under 3%. Between 1989 and 2003, it leveled off at around 5%. After 2003, the proportion increased noticeably, and reached 25.4%:34.0% in aged 40–49 years, 32.8% in aged 50–59 years, and 26.7% in aged 60–69 years. The increase in local cases and decrease in regional cases would be due to awareness of breast cancer, probably a result of developments in medical diagnostic technology. On the other hand, the steep increase of in situ cases might be due to screening. We need careful monitoring of the trends in breast cancer incidence by clinical stage.
Appendix
Available only for authorised users
Literature
2.
go back to reference Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am. 2004;42:793–806.CrossRefPubMed Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am. 2004;42:793–806.CrossRefPubMed
3.
go back to reference Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995;75:1619–26.CrossRefPubMed Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995;75:1619–26.CrossRefPubMed
5.
6.
go back to reference Chu KC, Kramer BS, Smart CR. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991;83:1636–43.CrossRefPubMed Chu KC, Kramer BS, Smart CR. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991;83:1636–43.CrossRefPubMed
7.
go back to reference Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.CrossRefPubMed Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.CrossRefPubMed
8.
go back to reference Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.CrossRefPubMed Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.CrossRefPubMed
9.
go back to reference Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed
10.
go back to reference Toyoda Y, Tabuchi T, Nakayama T, Hojo S, Yoshioka S, Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac J Cancer Priv. 2016;17:2847–52. Toyoda Y, Tabuchi T, Nakayama T, Hojo S, Yoshioka S, Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac J Cancer Priv. 2016;17:2847–52.
11.
go back to reference Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 6, 1987 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 6, 1987 (in Japanese).
12.
go back to reference Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 20, 1995 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 20, 1995 (in Japanese).
13.
go back to reference Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 34, 2005 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 34, 2005 (in Japanese).
14.
go back to reference Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 43, 2016 (in Japanese). Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 43, 2016 (in Japanese).
15.
16.
go back to reference Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 45, Cancer Incidence and Medical Care in Osaka in 1985, 1988 (in Japanese). Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 45, Cancer Incidence and Medical Care in Osaka in 1985, 1988 (in Japanese).
17.
go back to reference Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 80, Cancer Incidence and Medical Care in Osaka in 2011–2012 and the Survival in 2009, 2016 (in Japanese). Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 80, Cancer Incidence and Medical Care in Osaka in 2011–2012 and the Survival in 2009, 2016 (in Japanese).
Metadata
Title
Trends in the clinical stage distribution of breast cancer in Osaka, Japan
Authors
Yasuhiro Toyoda
Takahiro Tabuchi
Tomio Nakayama
Shigeyuki Hojo
Setsuko Yoshioka
Yukiko Wakabayashi
Yoshiichi Maeura
Publication date
01-03-2018
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2018
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0807-7

Other articles of this Issue 2/2018

Breast Cancer 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine